The Parliamentary Standing Committee on Health and Family Welfare in its 95th report on Demands for Grants 2016-17 of the Ministry of AYUSH noted that there has been recurring delay in amending the Drugs and Magic Remedies (Objectionable Advertisements ) Act 1954.
"The committee recommends that the Ministry should vigorously pursue the matter of amending the said Act and Rules thereunder.
"The committee also recommends that apart from giving sharper teeth to the Drugs and Magic Remedies Act, a provision should also be incorporated in the relevant rules to ban such practices and penalize offenders," the committee chaired by Ram Gopal Yadav said in its report.
The committee said that though the process of amending the said Act and Rules has been set in motion, its logical culmination is "still some distance away".
The committee said in its earlier reports it had been commenting upon the misleading advertisements concerning AYUSH remedies over TV, radio and in the print media and exhorting the Ministry to take necessary remedial measures.
It noted that the oft-repeated contention of the Ministry in this regard has been that due to ineffectiveness of the Drugs and Magic Remedies (Objectionable Advertisements) Act 1954, it has not been possible to take stringent action against the misleading and exaggerated claims of efficacy of AYUSH remedies.
The committee's report said that the Ministry had informed that the Department of Health and Family Welfare, under whose jurisdiction task force for suggesting amendments to the Act was constituted, has been requested to expedite consolidation of amendment provisions.
The Indian Medical Association (IMA) had recently issued a circular to all its 2.5 lakh members warning them not to advertise "no cure, no payment" or "guaranteed cure" claims stating both violated Medical Council of India (MCI) Code of Ethics Regulations as well as Drugs and Magic Remedies Act.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
